Enhabit (NYSE:EHAB) Sets New 1-Year High – What’s Next?

Enhabit, Inc. (NYSE:EHAB) shares reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as $14.11 and last traded at $14.0840, with a volume of 3908377 shares. The stock had previously closed at $13.66.

Analyst Ratings Changes

A number of analysts have commented on EHAB shares. Wolfe Research set a $12.00 target price on shares of Enhabit in a report on Thursday, January 8th. UBS Group reiterated a “neutral” rating and set a $13.80 price target (up from $12.00) on shares of Enhabit in a research note on Tuesday, February 24th. Deutsche Bank Aktiengesellschaft raised shares of Enhabit to a “buy” rating in a research report on Tuesday, January 13th. TD Cowen reaffirmed a “hold” rating and issued a $13.80 target price (up from $12.00) on shares of Enhabit in a report on Friday, March 6th. Finally, Citigroup reiterated a “buy” rating on shares of Enhabit in a research report on Tuesday, December 16th. Two investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $13.57.

Enhabit Stock Up 3.1%

The company has a market capitalization of $714.34 million, a PE ratio of -156.49 and a beta of 1.55. The company’s 50 day moving average is $12.33 and its two-hundred day moving average is $10.03. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.76.

Enhabit (NYSE:EHAB) last announced its quarterly earnings results on Wednesday, March 4th. The company reported $0.14 EPS for the quarter, hitting the consensus estimate of $0.14. Enhabit had a negative net margin of 0.43% and a positive return on equity of 4.71%. The business had revenue of $270.40 million for the quarter, compared to analysts’ expectations of $270.56 million. On average, analysts anticipate that Enhabit, Inc. will post 0.22 earnings per share for the current year.

Insider Activity

In other news, EVP Julie Diane Jolley sold 2,793 shares of Enhabit stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $13.63, for a total value of $38,068.59. Following the sale, the executive vice president directly owned 139,923 shares of the company’s stock, valued at approximately $1,907,150.49. The trade was a 1.96% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 3.40% of the company’s stock.

Hedge Funds Weigh In On Enhabit

Institutional investors have recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Enhabit by 4.4% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 29,813 shares of the company’s stock worth $262,000 after acquiring an additional 1,248 shares during the last quarter. Orion Porfolio Solutions LLC boosted its position in shares of Enhabit by 1.0% during the 3rd quarter. Orion Porfolio Solutions LLC now owns 144,016 shares of the company’s stock valued at $1,154,000 after acquiring an additional 1,361 shares during the last quarter. Strs Ohio boosted its position in shares of Enhabit by 10.9% during the 3rd quarter. Strs Ohio now owns 15,300 shares of the company’s stock valued at $123,000 after acquiring an additional 1,500 shares during the last quarter. Osaic Holdings Inc. grew its holdings in shares of Enhabit by 337.5% in the second quarter. Osaic Holdings Inc. now owns 2,616 shares of the company’s stock valued at $25,000 after purchasing an additional 2,018 shares in the last quarter. Finally, Tower Research Capital LLC TRC grew its holdings in shares of Enhabit by 82.9% in the second quarter. Tower Research Capital LLC TRC now owns 4,542 shares of the company’s stock valued at $44,000 after purchasing an additional 2,059 shares in the last quarter.

Enhabit Company Profile

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.